Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2010
10/13/2010CN1774281B Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
10/13/2010CN101861304A New thrombin function compounds and pharmaceutical compositions based on them
10/13/2010CN101861153A Peritoneal dialysate
10/13/2010CN101861142A Stabilisation of liquid-formulated factor VII(a) polypeptides by aldehyde-containing compounds
10/13/2010CN101857550A Method for producing 6-aminocaproic acid hydrochloride and 6-aminocaproic acid by using nylon-6 waste through depolymerization
10/13/2010CN101856486A Chinese medicament for treating hematochezia
10/13/2010CN101856462A Chinese medicinal composition for treating postpartum blood stasis
10/13/2010CN101856439A Chestnutsdispe capsule and preparation method thereof
10/13/2010CN101856431A Medicament for treating liver-kidney yin deficiency type anovulatory dysfunctional uterine bleeding, and preparation method and application thereof
10/13/2010CN101856393A Application of compound Yiganling composition in aspect of auxiliary treatment of chemotherapy of tumors
10/13/2010CN101856390A Slimming Chinese traditional medicament ointment
10/13/2010CN101856389A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and application thereof
10/13/2010CN101632681B Glycerol fructose liposome drug combination injection and preparation method thereof
10/13/2010CN101342152B Butylbenzene phthalein tablet and preparation method thereof
10/13/2010CN101336673B Water ice formulation capable of arresting blood after tonsil operation
10/13/2010CN101313964B Medicine for treating hydrocephalus
10/13/2010CN101240031B Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application
10/13/2010CN101235367B Method for preparing ganoderma sinensis streptokinase and application thereof
10/13/2010CN101190939B Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application
10/13/2010CN101117630B Preparation method of nattokinase powder and natto Brazil mushroom capsule
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812136 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
10/12/2010US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation
10/12/2010US7811991 Polypeptide therapeutic for treating ischemia associated with perioperative surgical procedure
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811314 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2375224C Human antithrombin variants
10/07/2010WO2010114943A1 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113960A1 Agent for inhibiting thickening of peritoneal membrane
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria
10/07/2010WO2010113498A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112547A1 Dialysis precursor composition
10/07/2010WO2010112538A1 A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
10/07/2010WO2010111951A1 Crystals of prasugrel hydrobromate
10/07/2010WO2010092571A3 Short beta-defensin-derived peptides
10/07/2010WO2010079510A3 Anti-rhd monoclonal antibodies
10/07/2010US20100256230 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
10/07/2010US20100256212 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
10/07/2010US20100256209 Compositions comprising ether compounds and pharmaceutical uses therefor
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256132 Il-12 modulatory compounds
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256110 Pharmaceutical solid dispersions
10/07/2010US20100256062 Allelic Variants of Human Factor VIII
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100255132 Novel botanical formulation for treating sickle cell disease
10/07/2010US20100255100 Stabilized protein crystals, formulations comprising them and methods of making them
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255000 Antidotes for factor xa inhibitors and methods of using the same
10/07/2010US20100254938 Formulation having mobilising activity
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757458A1 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof
10/07/2010CA2757189A1 Crystals of prasugrel hydrobromate
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2757082A1 A multipart fluid system and a system for regional citrate anticoagulation in an extracorporeal blood circuit
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/06/2010EP2236609A2 DNA-based aptamers for human cathepsin G
10/06/2010EP2236500A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
10/06/2010EP2236156A2 Methods for treating and diagnosing Psoriasis
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236106A1 Apparatus for stenting adapted for use in a bifurcated vessel comprising enhanced protection against embolism, restenosis and thrombus formation
10/06/2010EP1513554B1 Cd16a binding proteins and use for the treatment of immune disorders
10/06/2010CN1799575B Chinese medicinal dispersible tablet, its preparation process and ingredient detection method
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN101851339A Method for preparing donkey skin collagens
10/06/2010CN101851298A Sulfated galactan and preparation method thereof
10/06/2010CN101851247A Composition containing clopidogrel bisulfate crystal particles
10/06/2010CN101851209A Imidazole ethyl vanillic acid ether, preparation method and medicinal application thereof
10/06/2010CN101851162A Novel salvianolic acid compound L and preparation method and application thereof
10/06/2010CN101850124A Albumin nanometer-ultrasonic microbubble carrier tissue type plasminogen activator gene target system and preparation method thereof
10/06/2010CN101850105A Cefuroxime sodium composite medicine
10/06/2010CN101850096A External Chinese medicinal composition for treating hydrocephalus and preparation method thereof
10/06/2010CN101850031A Pueraria isoflavone capsule
10/06/2010CN101850002A Composition with function of improving nutritional anemia
10/06/2010CN101849988A Millettia extract and preparation method and application thereof
10/06/2010CN101849978A Method for extracting polyphenol active ingredient in geranium wilfordii through high-efficiency enzyme induction
10/06/2010CN101849948A Cefuroxime axetil composite medicine
10/06/2010CN101849943A Improved treatment for anemia using a HIF-alpha stabilising agent
10/06/2010CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
10/06/2010CN101849908A Oral fungi polysaccharide sulfate pro-liposome and preparation method thereof
10/06/2010CN101849907A Nanoemulsion of N-[4-(2,4 dimethoxy phenyl)-5-oxygroup-4,5-dihydro-[1,2] disulfide group-[4,3-b]-6-pyrryl]-3,5-di-trifluoromethyl benzamide and preparation method thereof
10/06/2010CN101849675A Dietary supplements containing natural ingredients
10/06/2010CN101284079B Chinese medicinal composition for curing the impotence and impairment of qi and blood
10/06/2010CN101279089B Donkey-hide gelatin calcium composition and preparing process thereof
10/06/2010CN101152205B Inosine injection and method of preparing the same
10/06/2010CN101028284B Externally-applied zeolite hemostat and its preparation
10/06/2010CN100998857B Kidney tonifying and enriching blood health-care tea and its preparation method
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7807682 Pyridyl cyanoguanidine compounds